Holders — by stockHoldings — by fund
Tetragon Partners GP Ltd
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001515070
$766.0M
disclosed book value
34
positions
54.5%
largest position share
Positions, as of 2026-09-30
top 37 of 34 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | PATHUIPATH INC | 32.5M | $417.3M | 54.5% |
| 2 | KGEIKOLIBRI GLOBAL ENERGY INC | 6.8M | $42.3M | 5.5% |
| 3 | SLNSILENCE THERAPEUTICS PLC | 2.4M | $26.6M | 3.5% |
| 4 | PHVSPharvaris Nv | 838,247 | $26.6M | 3.5% |
| 5 | IONSIONIS PHARMACEUTICALS INC | 440,930 | $19.7M | 2.6% |
| 6 | AUTLAUTOLUS THERAPEUTICS LTD | 9.5M | $18.4M | 2.4% |
| 7 | ARWRARROWHEAD PHARMACEUTICALS IN | 264,040 | $17.3M | 2.3% |
| 8 | LYFTLYFT INC | 1.0M | $15.0M | 2% |
| 9 | WKWORKIVA INC | 225,000 | $15.0M | 2% |
| 10 | MBXMBX BIOSCIENCES INC | 220,647 | $12.9M | 1.7% |
| 11 | DFTXDEFINIUM THERAPEUTICS INC | 310,892 | $11.8M | 1.5% |
| 12 | CXMSPRINKLR INC | 2.2M | $10.9M | 1.4% |
| 13 | CLDXCELLDEX THERAPEUTICS INC NEW | 295,941 | $9.6M | 1.3% |
| 14 | IMVTIMMUNOVANT INC | 275,219 | $9.3M | 1.2% |
| 15 | HRMYHARMONY BIOSCIENCES HLDGS IN | 226,677 | $8.9M | 1.2% |
| 16 | ALKTALKAMI TECHNOLOGY INC | 650,000 | $8.9M | 1.2% |
| 17 | ALKSAlkermes PLC | 206,778 | $8.4M | 1.1% |
| 18 | DYNDYNE THERAPEUTICS INC | 511,280 | $8.2M | 1.1% |
| 19 | RLAYRELAY THERAPEUTICS INC | 447,235 | $8.1M | 1.1% |
| 20 | AGIOAGIOS PHARMACEUTICALS INC | 215,529 | $7.2M | 0.9% |
| 21 | CELCCELCUITY INC | 87,421 | $7.0M | 0.9% |
| 22 | NBIXNEUROCRINE BIOSCIENCES INC | 47,014 | $6.7M | 0.9% |
| 23 | KRYSKRYSTAL BIOTECH INC | 19,668 | $6.5M | 0.9% |
| 24 | AXSMAXSOME THERAPEUTICS INC. | 35,000 | $6.5M | 0.8% |
| 25 | WBDWARNER BROS DISCOVERY INC | 200,000 | $6.2M | 0.8% |
| 26 | NKTRNEKTAR THERAPEUTICS | 101,645 | $6.2M | 0.8% |
| 27 | SLNSILENCE THERAPEUTICS PLCCALL | 500,000 | $5.5M | 0.7% |
| 28 | UBERUBER TECHNOLOGIES INC | 71,428 | $4.9M | 0.6% |
| 29 | SNOWSNOWFLAKE INC | 10,000 | $3.4M | 0.4% |
| 30 | ANTXAN2 THERAPEUTICS INC | 603,424 | $3.2M | 0.4% |
| 31 | ANNXANNEXON INC | 655,948 | $2.8M | 0.4% |
| 32 | AGIOAGIOS PHARMACEUTICALS INCCALL | 50,000 | $1.7M | 0.2% |
| 33 | GLUEMONTE ROSA THERAPEUTICS INCCALL | 100,000 | $1.2M | 0.2% |
| 34 | GLUEMONTE ROSA THERAPEUTICS INC | 56,052 | $668,700 | 0.1% |
| 35 | TECXTECTONIC THERAPEUTIC INC | 26,798 | $624,125 | 0.1% |
| 36 | SLGLSol-gel Technologies Ltd | 8,307 | $617,044 | 0.1% |
| 37 | TENXTENAX THERAPEUTICS INCCALL | 75,100 | $141,939 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.